Centogene NV
NASDAQ:CNTG
Centogene NV
NASDAQ:CNTG
Price:
0.364 USD
0.55%
Market Closed
Updated:
Jun 9, 2024
Centogene NV
Accumulated Depreciation
|
Centogene NV
Accumulated Depreciation Peer Comparison
Comparables:
BNTX
MOR
CVAC
IMTX
BIO
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Centogene NV
NASDAQ:CNTG
|
Accumulated Depreciation
-€30.8m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Accumulated Depreciation
-€211.8m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
MorphoSys AG
XETRA:MOR
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Accumulated Depreciation
-€37.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Accumulated Depreciation
-€22.9m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Centogene NV's Accumulated Depreciation?
Accumulated Depreciation
-30.8m
EUR
-30.8m
EUR
Based on the financial report for Dec 31, 2023, Centogene NV's Accumulated Depreciation amounts to -30.8m EUR.
What is Centogene NV's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-28%
-28%
Over the last year, the Accumulated Depreciation growth was -17%. The average annual Accumulated Depreciation growth rates for Centogene NV have been -32% over the past three years , -28% over the past five years .
You don't have any saved screeners yet
